261 related articles for article (PubMed ID: 7047337)
1. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
Giusti G; Ruggiero G; Galanti B; Piccinino F; Russo M; Galante D; Sagnelli E; Utili R; Pasquale G; Nardiello S; Aloisio V
Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver.
Giusti G; Piccinino F; Galanti B; Sagnelli E; Ruggiero G; Gallo C
Hepatogastroenterology; 1984 Feb; 31(1):24-9. PubMed ID: 6698485
[TBL] [Abstract][Full Text] [Related]
3. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
Tanno H; Fay O; Roldán L; Vorovioff J
Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of chronic hepatitis (author's transl)].
Arnold W; Meyer zum Büschenfelde KH
Leber Magen Darm; 1981 Apr; 11(2):73-80. PubMed ID: 6164895
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic active hepatitis--present state. The pros and cons of immunosuppressive therapy.
Thaler H
Hepatogastroenterology; 1984 Feb; 31(1):6-11. PubMed ID: 6698488
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy in chronic liver disease.
Sherlock S
Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
[TBL] [Abstract][Full Text] [Related]
7. Chronic active hepatitis in Italy: a multicentric study on clinical and laboratory data of 1154 cases. A report from the study group for CAH of the Italian Association for the Study of the Liver.
Hepatogastroenterology; 1983 Aug; 30(4):126-30. PubMed ID: 6629302
[TBL] [Abstract][Full Text] [Related]
8. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
[TBL] [Abstract][Full Text] [Related]
9. [Results and prognostic factors in the treatment of chronic active hepatitis with prednisone and azathioprine].
Jorge AD; Sánchez D
Acta Gastroenterol Latinoam; 1985; 15(4):233-41. PubMed ID: 3842554
[TBL] [Abstract][Full Text] [Related]
10. HLA antigens in chronic active hepatitis.
Pár A; Bajtai G; Gyódi E; Ambrus M; Hernádi E; Tényi I
Acta Med Acad Sci Hung; 1980; 37(1):17-24. PubMed ID: 7457016
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy reviews: chronic hepatitis.
Augur NA
Am J Hosp Pharm; 1978 Oct; 35(10):1222-6. PubMed ID: 358829
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic evaluation of chronic aggressive nepatitis and its relation to the Australian antigen.
Jorge AD; Sanchez D
Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):179-84. PubMed ID: 665118
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of chronic hepatitis. Results of a retrospective study.
Thaler H
Tokai J Exp Clin Med; 1980 Jul; 5(3):361-6. PubMed ID: 7222126
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B].
Kim JM; Choe BH; Chu MA; Cho SM
Korean J Hepatol; 2009 Jun; 15(2):168-78. PubMed ID: 19581769
[TBL] [Abstract][Full Text] [Related]
15. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
Lam KC; Lai CL; Trepo C; Wu PC
N Engl J Med; 1981 Feb; 304(7):380-6. PubMed ID: 7005678
[TBL] [Abstract][Full Text] [Related]
16. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer.
Lau GK; Lok AS; Liang RH; Lai CL; Chiu EK; Lau YL; Lam SK
Hepatology; 1997 Jun; 25(6):1497-501. PubMed ID: 9185774
[TBL] [Abstract][Full Text] [Related]
17. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of chronic hepatitis (author's transl)].
Auer IO
Leber Magen Darm; 1980 Oct; 10(5):251-8. PubMed ID: 6162069
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.
Chung HT; Lai CL; Lok AS
Hepatology; 1995 Jul; 22(1):25-9. PubMed ID: 7601418
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
